Indinavir (Crixivan) Research
- HIV JournalView: Study Ties Insulin Resistance to NRTIs, Not PIs (September 2005)
d4T and 3TC are associated with insulin resistance and high insulin levels; indinavir is associated only with elevated insulin levels; and no link to insulin abnormalities is found for AZT or ddI.
From TheBodyPRO.com
- High Dose of Vitamin C Significantly Reduces Indinavir Levels in Pilot Study (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- "Mono"-Therapy for HIV Infection Using Ritonavir-Boosted Indinavir (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Indinavir or Boosted Indinavir? (March 2002)
In Project Inform Perspective, from Project Inform
- Ingrown Toenails Still a Possible Side Effect (November 2001)
Indinavir-ritonavir interaction is possible culprit.
In HIV Treatment ALERTS!, from The Center for AIDS
- Lack of Clinically Relevant Drug-Drug Interactions Between Tenofovir DF and Efavirenz, Indinavir, Lamivudine and Lopinavir/Ritonavir in Healthy Subjects (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from TheBodyPRO.com
- A Phase IV Randomized Open-Label Multicenter Trial to Evaluate Safety and Efficacy of Indinavir/Ritonavir (800/100 mg BID) vs. Saquinavir/Ritonavir (1,000/100 mg BID) in Adult HIV-1 Infection: The Max Cmin 1 Trial (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from TheBodyPRO.com
- Differential In Vitro Effects of Indinavir, Nelfinavir and Amprenavir On Cell Differentiation, Insulin Sensitivity and Apoptosis in an Adapted Adipose Cell Model -- Preventive Impact of Rosiglitazone (October 25, 2001)
In 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, from TheBodyPRO.com
- Abacavir/Combivir Is Comparable to Indinavir/Combivir in HIV-1 Infected Antiretroviral Therapy Naive Adults: Preliminary Results of a 48-Week Open-Label Study (CNA3014) (July 10, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Therapeutic Drug Monitoring (TDM) of Nelfinavir (NFV) and Indinavir (IDV) In Treatment-Naive Patients Improves Therapeutic Outcome After 1 Year: Results from ATHENA (July 9, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- High Blood Pressure With Indinavir (May 25, 2001)
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Protease Combinations: Ritonavir and Indinavir One Year Later (March 15, 2001)
Developments from the 8th Conference on Retroviruses and Opportunistic Infections.
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- ACTG 5056: Metabolic Status and Cardiovascular Disease Risk for a Cohort of HIV-1-Infected Persons Durably Suppressed on an Indinavir-Containing Regimen (ACTG 372A) (February 7, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Indinavir/Ritonavir Versus Indinavir in Combination With AZT/3TC for Treatment of HIV in Nucleoside-Experienced Patients: A Randomized, Open-Label Trial (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Preliminary Results From Indinavir (IDV) and Ritonavir (RTV) in a Once-Daily Regimen (Marck 103/104) (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Is Once Daily Indinavir With Ritonavir On the Way? (December 20, 2000)
From Canadian AIDS Treatment Information Exchange
- Saliva Useful for Monitoring Indinavir Levels in HIV-Infected Patients (October 2000)
In Body Positive, from Body Positive
- Abacavir vs. Indinavir in Therapy-Naive People (CNA3014) (August 17, 2000)
In STEP Ezine, from Seattle Treatment Education Project
- Ritonavir Intensification of Indinavir in People Without Complete HIV Suppression (August 17, 2000)
In STEP Ezine, from Seattle Treatment Education Project
- Long-Term Comparative Outcomes of Indinavir (IDV) vs. Nelfinavir (NFV)-Based HAART in Naive Patients in Routine Clinical Practice (July 12, 2000)
The Body's Coverage of the XIII International AIDS Conference.
In The XIII International AIDS Conference, from TheBodyPRO.com
- A Randomized, Controlled, Open-label Study Comparing the Adherence and Convenience of Continuing Indinavir Q8H vs. Switching to Norvir/Indinavir 400 mg/400 mg BID (The NICE Study) (July 12, 2000)
In The XIII International AIDS Conference, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
